Warning: The NCBI web site requires JavaScript to function. more...
Antiviral therapy in acute viral hepatitis B: why and when.
Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Monaco A, Perrella O.
Infect Agent Cancer. 2009 Apr 1;4:5.
Related citations
[Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Seehofer D, Rayes N, Bechstein WO, Naumann U, Neuhaus R, Berg T, Hopf U, Langrehr JM, Steinmüller T, Platz KP, Müller AR, Neuhaus P.
Z Gastroenterol. 2000 Sep;38(9):773-83. German.
[Acute hepatitis B: is antiviral therapy indicated? Two case reports].
Girke J, Wedemeyer H, Wiegand J, Manns MP, Tillmann HL.
Dtsch Med Wochenschr. 2008 May;133(22):1178-82. German.
Bio-mathematical models of viral dynamics to tailor antiviral therapy in chronic viral hepatitis.
Brunetto MR, Colombatto P, Bonino F.
World J Gastroenterol. 2009 Feb 7;15(5):531-7.
Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O.
Infect Agent Cancer. 2009 Jan 16;4:2.
Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.
Castéra L, Hézode C, Roudot-Thoraval F, Lonjon I, Zafrani ES, Pawlotsky JM, Dhumeaux D.
Gut. 2004 Mar;53(3):420-4.
Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.
Am J Gastroenterol. 2003 May;98(5):1150-4.
Viral hepatitis in older adults.
Marcus EL, Tur-Kaspa R.
J Am Geriatr Soc. 1997 Jun;45(6):755-63. Review.
Therapy of viral hepatitis.
Hoofnagle JH.
Digestion. 1998 Aug;59(5):563-78. Review.
The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus.
Niu J, Wang Y, Dixon R, Bowden S, Qiao M, Einck L, Locarnini S.
Antiviral Res. 1993 Jun;21(2):155-71.
Antiviral therapy of chronic hepatitis B.
Zoulim F.
Antiviral Res. 2006 Sep;71(2-3):206-15. Epub 2006 Apr 25. Review.
HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C.
Wai CT, Chu CJ, Hussain M, Lok AS.
Hepatology. 2002 Dec;36(6):1425-30.
[Genetic diagnosis of hepatitis B and C].
Gervain J.
Orv Hetil. 2003 Dec 28;144(52):2547-52. Review. Hungarian.
[Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
Pár A, Tornai I, Szalay F.
Orv Hetil. 2007 May 6;148(18):819-26. Hungarian.
Interferon system in acute viral hepatitis.
Levin S, Hahn T.
Lancet. 1982 Mar 13;1(8272):592-4.
[Use of polymerase chain reaction in clinical diagnostic laboratories in viral hepatitis B and C].
Skvortsov SV, Lytsar' BN, Samokhodskaia LM, Vasil'ev AP, Kvasovka VV, Shaĭkhaev GO.
Klin Lab Diagn. 1998 Jan;(1):42-4. Russian.
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.
Chuma M, Hige S, Kamiyama T, Meguro T, Nagasaka A, Nakanishi K, Yamamoto Y, Nakanishi M, Kohara T, Sho T, Yamamoto K, Horimoto H, Kobayashi T, Yokoo H, Matsushita M, Todo S, Asaka M.
J Gastroenterol. 2009;44(9):991-9. Epub 2009 Jun 25.
Hepatitis viruses: genetic variants and clinical significance.
Blum HE.
Int J Clin Lab Res. 1997;27(4):213-24. Review.
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.
Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, Trabaud MA, Chevallier P, Chevallier M, Zoulim F, Trépo C.
J Med Virol. 2007 Aug;79(8):1075-81.
Hepatitis viruses and liver transplantation.
Samuel D, Feray C, Bismuth H.
J Gastroenterol Hepatol. 1997 Oct;12(9-10):S335-41. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on